SLC5A2 and type 2 diabetes mellitus: Despite significant research and the implementation of new treatment protocols, such as the increased use of GLP-1 receptor agonists and SGLT2 inhibitors, managing type 2 diabetes remains a complex challenge requiring a multifaceted approach [11].